- Trials with a EudraCT protocol (1,010)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,010 result(s) found for: Hospital discharge.
Displaying page 1 of 51.
EudraCT Number: 2016-003557-15 | Sponsor Protocol Number: HMB-ICU | Start Date*: 2018-08-31 | |||||||||||
Sponsor Name:Guy's and St Thomas NHS Foundation Trust | |||||||||||||
Full Title: A Study to Investigate the Effect of β-Hydroxy-β-Methylbutyrate (HMB) on Skeletal Muscle Wasting in Early Critical Illness. | |||||||||||||
Medical condition: Critical illness | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002298-25 | Sponsor Protocol Number: 20203331 | Start Date*: 2021-09-15 |
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario La Paz (FIBHULP) | ||
Full Title: A multicenter, adaptive, prospective, randomized trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003703-19 | Sponsor Protocol Number: 18-002 | Start Date*: 2020-04-20 |
Sponsor Name:RWTH Aachen University represented by the Rector himself, represented by the Dean of the Medical Faculty | ||
Full Title: The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial | ||
Medical condition: Nutritionally high-risk critically ill mechanically ventilated patients. In this sub-study, eligible and enrolled patients randomized to the high protein dose group will achieve its protein goals b... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2023-000010-18 | Sponsor Protocol Number: WATERLAND | Start Date*: 2023-03-23 | |||||||||||
Sponsor Name:Enrique de Madaria | |||||||||||||
Full Title: Normal saline versus lactated Ringer’s solution for acute pancreatitis resuscitation, an open-label multicenter randomized controlled trial: the WATERLAND trial | |||||||||||||
Medical condition: Acute pancreatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003661-19 | Sponsor Protocol Number: 006 | Start Date*: 2020-10-27 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Beta-blockade with landiolol in out-of-hospital cardiac arrest: a randomized, double-blind, placebo-controlled, pilot trial | ||
Medical condition: out-of-hospital cardiac arrest | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: AT (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000839-21 | Sponsor Protocol Number: DREPADOL | Start Date*: 2019-06-17 | |||||||||||
Sponsor Name:Centre Hospitalier Intercommunal de Créteil | |||||||||||||
Full Title: Evaluation of the efficacy and safety of aprepitant in the management of vaso-occlusive crisis in sickle cell children: randomized, single-center, randomized, phase IIb/III prospective study | |||||||||||||
Medical condition: vaso-occlusive crisis for patients with sickle cell disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Not Authorised) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004260-22 | Sponsor Protocol Number: ELFIN01 | Start Date*: 2013-08-28 |
Sponsor Name:University of Oxford | ||
Full Title: A multi-centre randomised placebo-controlled trial of prophylactic enteral lactoferrin supplementation to prevent late-onset invasive infection in very preterm infants. | ||
Medical condition: Late onset invasive infection in very preterm infants | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001616-18 | Sponsor Protocol Number: TACTIC-COVID | Start Date*: 2020-04-18 | |||||||||||
Sponsor Name:Fundació Clinic per a la Recerca Biomèdica | |||||||||||||
Full Title: Treatment with inhaled corticoids in patients with COVID-19 admitted to hospital with pneumonia | |||||||||||||
Medical condition: COVID19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002166-13 | Sponsor Protocol Number: HUB-MdI-ICAT-COVID-201 | Start Date*: 2020-07-09 | |||||||||||||||||||||
Sponsor Name:Dr. Ramón Lleonart Bellfill / Dr. Xavier Corbella Virós | |||||||||||||||||||||||
Full Title: Randomized, open, multicenter phase II clinical trial, proof of concept, to evaluate efficacy and safety of Icatibant in hospitalized patients with SARS-COV-2 (COVID-19) without assisted ventilatio... | |||||||||||||||||||||||
Medical condition: Pneumonia caused by COVID-19 | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004715-20 | Sponsor Protocol Number: GLARGL07710 | Start Date*: 2016-02-25 | |||||||||||
Sponsor Name:SANOFI-AVENTIS, S.A. | |||||||||||||
Full Title: Phase IV study to evaluate the safety and efficacy of the treatment of hyperglycemia with Gla-300 in basal-bolus regimen in hospitalised T2D patients poorly controlled with basal insulin and/or non... | |||||||||||||
Medical condition: Type 2 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002078-38 | Sponsor Protocol Number: SU/2016/6033 | Start Date*: 2017-12-06 | |||||||||||||||||||||
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | |||||||||||||||||||||||
Full Title: Effectiveness, cost effectiveness and safety of gabapentin versus placebo as an adjunct to multimodal pain regimens in surgical patients: A placebo controlled randomised controlled trial with blind... | |||||||||||||||||||||||
Medical condition: Post surgery pain management | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000850-39 | Sponsor Protocol Number: P141103 | Start Date*: 2019-11-19 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Assessment of Loading with the P2Y12 inhibitor Ticagrelor or clopidogrel to Halt ischemic Events in patients Undergoing elective coronary Stenting: the ALPHEUS study. | |||||||||||||
Medical condition: PCI-related myocardial infarction (MI type 4) or injury (I) within 48 hours (or at hospital discharge if earlier than 48 hours) of elective PCI/stent | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003117-18 | Sponsor Protocol Number: HUB-INF-ALBUCAP-402 | Start Date*: 2019-07-10 | |||||||||||
Sponsor Name:Dr. Jordi Carratalà Fernández (Servicio de Enfermedades Infecciosas) del Hospital Universitario de Bellvitge | |||||||||||||
Full Title: A phase III randomized, controlled, open label multicenter clinical trial, with two parallel groups, to evaluate the efficacy of albumin administration in patients hospitalized with community-acqui... | |||||||||||||
Medical condition: Community-acquired pneumonia (CAP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003527-14 | Sponsor Protocol Number: D9480C00023 | Start Date*: 2021-12-17 | |||||||||||
Sponsor Name:ASTRAZENECA AB | |||||||||||||
Full Title: An Open-Label, Randomised, Phase 4 Study of Continuing Sodium Zirconium Cyclosilicate (SZC) after Discharge in Participants with Chronic Kidney Disease treated for Hyperkalaemia | |||||||||||||
Medical condition: Patients with Chronic Kidney Disease treated for Hyperkalaemia whilst in hospital, who are normokalemic and established on maintenance dose of SZC at discharge. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) ES (Ongoing) FR (Completed) NL (Completed) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004880-29 | Sponsor Protocol Number: HUB-INF-RADICAP | Start Date*: 2019-10-02 | |||||||||||
Sponsor Name:Dr. Jordi Carratalà Fernández (Servicio de Enfermedades Infecciosas) del Hospital Universitario de Bellvitge | |||||||||||||
Full Title: Phase IV randomized, controlled, open and multicentre clinical trial with two parallel groups, to assess the impact of integral molecular tests in the antimicrobial use in community-acquired pneumo... | |||||||||||||
Medical condition: Community-acquired pneumonia (CAP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004248-11 | Sponsor Protocol Number: Ahus-ATHENIAN | Start Date*: 2021-11-10 |
Sponsor Name:Akershus University Hospital | ||
Full Title: Antibiotic THErapy iN vIral Airway iNfections (ATHENIAN): An open labelled randomized controlled pragmatic trial to evaluate the efficacy and safety of discontinuing antibiotic therapy in adult pat... | ||
Medical condition: Patients with viral respiratory tract infection (influenza virus, parainfluenza virus, respiratory syncytial virus or human metapneumovirus) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001005-25 | Sponsor Protocol Number: IRONSTOMACH-01 | Start Date*: 2019-09-19 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: Preoperative intravenous iron therapy in patients with gastric cancer | ||
Medical condition: Gastric Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001160-28 | Sponsor Protocol Number: MedOPP376 | Start Date*: 2020-04-09 | |||||||||||
Sponsor Name:Medica Scientia Innovation Research S.L. (MEDSIR) | |||||||||||||
Full Title: A Randomized, Controlled, Open-Label, Phase II Trial to Evaluate the Efficacy and Safety of Tocilizumab Combined with Pembrolizumab (MK-3475) in Patients with Coronavirus Disease 2019 (COVID-19)-Pn... | |||||||||||||
Medical condition: Coronavirus Disease 2019 (COVID-19)-Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000792-11 | Sponsor Protocol Number: | Start Date*: 2014-07-09 |
Sponsor Name:University of Warwick | ||
Full Title: Prehospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug administration In Cardiac arrest | ||
Medical condition: Out of hospital cardiac arrest | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004446-29 | Sponsor Protocol Number: LIBERAL-Trial | Start Date*: 2017-10-30 | |||||||||||
Sponsor Name:University Hospital Wuerzburg, Institution under public law, represented by the Medical Director | |||||||||||||
Full Title: Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients | |||||||||||||
Medical condition: Elderly patients (>= 70 years) undergoing intermediate- or high-risk non-cardiac surgery | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
